Literature DB >> 16085908

Modification of rapid human immunodeficiency virus (HIV) antibody assay protocols for detecting recent HIV seroconversion.

Stephen D Soroka1, Timothy C Granade, Debra Candal, Bharat S Parekh.   

Abstract

Assay protocols of three rapid human immunodeficiency virus (HIV) assays, OraQuick-1/2, SeroStrip-1/2, and Determine-1/2, were modified to detect recent HIV seroconversion using a higher dilution of serum specimens. Optimal predilution of specimens resulted in negative test results during early periods of seroconversion (about 6 months), when antibody levels were low. A total of 269 seropositive specimens from routine HIV type 1 testing and from commercial sources (low-titer and seroconversion panels) were tested, and results were recorded as negative (score=0) or positive using intensity scores from 0.5 (weak positive) to 4 (strongly positive). The same specimens were previously tested by a less sensitive (LS) enzyme immunoassay (EIA), Abbott 3A 11-LS, and were classified as recent or long-term infections based on the standardized optical density (SOD) cutoff of 0.75. Overall concordance of >94% was observed between 3A 11-LS and modified rapid tests (RT-LSs) for detecting and distinguishing recent HIV seroconversion from long-term HIV infection (kappa statistics=0.894 to 0.901). Moreover, intensity scores on RT-LSs correlated well with median 3A 11-LS SOD values (R(2)>0.98). Our results indicate that rapid HIV tests can be modified to detect recent seroconversion with results comparable to those from less sensitive EIA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16085908      PMCID: PMC1182197          DOI: 10.1128/CDLI.12.8.918-921.2005

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  17 in total

1.  Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method.

Authors:  Barbara Suligoi; Claudio Galli; Mario Massi; Fiorella Di Sora; Mauro Sciandra; Patrizio Pezzotti; Olga Recchia; Francesco Montella; Alessandro Sinicco; Giovanni Rezza
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

2.  HIV seroincidence among patients at clinics for sexually transmitted diseases in nine cities in the United States.

Authors:  Hillard Weinstock; Monica Dale; Marta Gwinn; Glen A Satten; Denise Kothe; Joanne Mei; Janet Royalty; Laurie Linley; Carol Fridlund; Bharat Parekh; Bhupat D Rawal; Michael P Busch; Robert S Janssen
Journal:  J Acquir Immune Defic Syndr       Date:  2002-04-15       Impact factor: 3.731

3.  Evaluation of rapid diagnostic tests for the detection of human immunodeficiency virus types 1 and 2, hepatitis B surface antigen, and syphilis in Ho Chi Minh City, Vietnam.

Authors:  T X Lien; N T Tien; G F Chanpong; C T Cuc; V T Yen; R Soderquist; K Laras; A Corwin
Journal:  Am J Trop Med Hyg       Date:  2000-02       Impact factor: 2.345

4.  Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence.

Authors:  Bharat S Parekh; M Susan Kennedy; Trudy Dobbs; Chou-Pong Pau; Robert Byers; Timothy Green; Dale J Hu; Suphak Vanichseni; Nancy L Young; Kachit Choopanya; Timothy D Mastro; J Steven McDougal
Journal:  AIDS Res Hum Retroviruses       Date:  2002-03-01       Impact factor: 2.205

5.  Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection.

Authors:  B S Parekh; C P Pau; M S Kennedy; T L Dobbs; J S McDougal
Journal:  AIDS Res Hum Retroviruses       Date:  2001-01-20       Impact factor: 2.205

6.  Evaluation of a sensitive/less-sensitive testing algorithm using the 3A11-LS assay for detecting recent HIV seroconversion among individuals with HIV-1 subtype B or E infection in Thailand.

Authors:  B S Parekh; D J Hu; S Vanichseni; G A Satten; D Candal; N L Young; D Kitayaporn; L O Srisuwanvilai; S Rakhtam; R Janssen; K Choopanya; T D Mastro
Journal:  AIDS Res Hum Retroviruses       Date:  2001-03-20       Impact factor: 2.205

7.  Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection.

Authors:  Bhupat D Rawal; Azucena Degula; Ludmila Lebedeva; Robert S Janssen; Frederick M Hecht; Haynes W Sheppard; Michael P Busch
Journal:  J Acquir Immune Defic Syndr       Date:  2003-07-01       Impact factor: 3.731

8.  Evaluation of a sensitive/less sensitive testing algorithm using the bioMérieux Vironostika-LS assay for detecting recent HIV-1 subtype B' or E infection in Thailand.

Authors:  Carrie L Young; Dale J Hu; Robert Byers; Suphak Vanichseni; Nancy L Young; Robert Nelson; Philip A Mock; Kachit Choopanya; Robert Janssen; Timothy D Mastro; Joanne V Mei
Journal:  AIDS Res Hum Retroviruses       Date:  2003-06       Impact factor: 2.205

9.  Improved classification of recent HIV-1 infection by employing a two-stage sensitive/less-sensitive test strategy.

Authors:  Niel T Constantine; Anne M Sill; Noreen Jack; Kristen Kreisel; Jeffrey Edwards; Thomas Cafarella; Harry Smith; Courtenay Bartholomew; Farley R Cleghorn; William A Blattner
Journal:  J Acquir Immune Defic Syndr       Date:  2003-01-01       Impact factor: 3.731

10.  HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassay.

Authors:  Dale J Hu; Suphak Vanichseni; Philip A Mock; Nancy L Young; Trudy Dobbs; Robert H Byers; Kachit Choopanya; Frits van Griensven; Dwip Kitayaporn; J Steven McDougal; Jordan W Tappero; Timothy D Mastro; Bharat S Parekh
Journal:  AIDS Res Hum Retroviruses       Date:  2003-09       Impact factor: 2.205

View more
  14 in total

1.  A comprehensive evaluation of the proficiency testing program for the HIV-1 BED incidence assay.

Authors:  Trudy Dobbs; Xin Liu; Rebecca Anderson; John Nkengasong; Bharat S Parekh
Journal:  J Clin Microbiol       Date:  2011-08-10       Impact factor: 5.948

2.  The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals.

Authors:  Christine M Hogan; Victor Degruttola; Xin Sun; Susan A Fiscus; Carlos Del Rio; C Bradley Hare; Martin Markowitz; Elizabeth Connick; Bernard Macatangay; Karen T Tashima; Beatrice Kallungal; Rob Camp; Tia Morton; Eric S Daar; Susan Little
Journal:  J Infect Dis       Date:  2011-12-15       Impact factor: 5.226

Review 3.  Diagnosis of Human Immunodeficiency Virus Infection.

Authors:  Bharat S Parekh; Chin-Yih Ou; Peter N Fonjungo; Mireille B Kalou; Erin Rottinghaus; Adrian Puren; Heather Alexander; Mackenzie Hurlston Cox; John N Nkengasong
Journal:  Clin Microbiol Rev       Date:  2018-11-28       Impact factor: 26.132

4.  Comparison of two rapid human immunodeficiency virus (HIV) assays, Determine HIV-1/2 and OraQuick Advance Rapid HIV-1/2, for detection of recent HIV seroconversion.

Authors:  Rachana Kshatriya; Ada A Cachafeiro; Ryan J S Kerr; Julie A E Nelson; Susan A Fiscus
Journal:  J Clin Microbiol       Date:  2008-08-06       Impact factor: 5.948

5.  The effect of viral suppression on cross-sectional incidence testing in the johns hopkins hospital emergency department.

Authors:  Oliver Laeyendecker; Richard E Rothman; Charlamaine Henson; Bobbi Jo Horne; Kerunne S Ketlogetswe; Chadd K Kraus; Judy Shahan; Gabor D Kelen; Thomas C Quinn
Journal:  J Acquir Immune Defic Syndr       Date:  2008-06-01       Impact factor: 3.731

6.  Better control of early viral replication is associated with slower rate of elicited antiviral antibodies in the detuned enzyme immunoassay during primary HIV-1C infection.

Authors:  Vladimir Novitsky; Rui Wang; Lemme Kebaabetswe; Jamieson Greenwald; Raabya Rossenkhan; Sikhulile Moyo; Rosemary Musonda; Elias Woldegabriel; Stephen Lagakos; M Essex
Journal:  J Acquir Immune Defic Syndr       Date:  2009-10-01       Impact factor: 3.731

Review 7.  Current and future assays for identifying recent HIV infections at the population level.

Authors:  Joanna Smoleń-Dzirba; Tomasz J Wąsik
Journal:  Med Sci Monit       Date:  2011-05

8.  Misclassification of recent HIV-1 seroconversion in sub-Saharan Africa using the sensitive/less sensitive technique.

Authors:  Kwabena O Duedu; Anna A Hayford; Kwamena W Sagoe
Journal:  Virol J       Date:  2011-04-17       Impact factor: 4.099

9.  Indeterminate and discrepant rapid HIV test results in couples' HIV testing and counselling centres in Africa.

Authors:  Debrah I Boeras; Nicole Luisi; Etienne Karita; Shila McKinney; Tyronza Sharkey; Michelle Keeling; Elwyn Chomba; Colleen Kraft; Kristin Wall; Jean Bizimana; William Kilembe; Amanda Tichacek; Angela M Caliendo; Eric Hunter; Susan Allen
Journal:  J Int AIDS Soc       Date:  2011-04-08       Impact factor: 5.396

10.  Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes.

Authors:  Yen T Duong; Reshma Kassanjee; Alex Welte; Meade Morgan; Anindya De; Trudy Dobbs; Erin Rottinghaus; John Nkengasong; Marcel E Curlin; Chonticha Kittinunvorakoon; Boonyos Raengsakulrach; Michael Martin; Kachit Choopanya; Suphak Vanichseni; Yan Jiang; Maofeng Qiu; Haiying Yu; Yan Hao; Neha Shah; Linh-Vi Le; Andrea A Kim; Tuan Anh Nguyen; William Ampofo; Bharat S Parekh
Journal:  PLoS One       Date:  2015-02-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.